Kestine Smelt

Ebastine, the active ingredient in Kestine Smelt, is a second‑generation H1 antihistamine presented as an oral tablet for oral use. It is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria in adults and adolescents and is commonly prescribed in the European market.

GNH USA supplies Kestine Smelt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory conformity for global distribution with reliable logistics and support for regulatory approvals.

Ebastine is used to manage allergic conditions by targeting histamine‑mediated pathways. - Allergic rhinitis (seasonal): relieves nasal congestion, sneezing, itching and rhinorrhea. - Allergic rhinitis (perennial): controls year‑round nasal symptoms and improves quality of life. - Chronic idiopathic urticaria: reduces hives, itching and associated discomfort.

Ebastine may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate headache reported. - Dry mouth: sensation of oral dryness. - Drowsiness: occasional mild sedation. - Fatigue: feeling of tiredness.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or throat requiring immediate medical attention. - Stevens‑Johnson syndrome: severe skin reaction with blistering and detachment. - Anaphylaxis: rare systemic allergic reaction that can be life‑threatening.

When prescribing ebastine, clinicians should consider several precautionary measures to ensure safe use. - Pregnancy: safety not established; use only if potential benefit justifies risk. - Breastfeeding: avoid unless benefit outweighs potential risk to infant. - Elderly patients: monitor for increased sedation or dizziness. - Hepatic or renal impairment: dose adjustment may be required. - Concomitant CNS depressants: may enhance drowsiness. - Store at ambient temperature: keep in original packaging, protect from moisture.

Ebastine can interact with other medicines, altering its plasma levels or enhancing side‑effects.

Major Interactions (Avoid): - Ketoconazole: strong CYP3A4 inhibition can raise ebastine concentrations, increasing risk of adverse effects. - Ritonavir: potent CYP3A4 inhibitor may lead to elevated ebastine levels and heightened side‑effects.

Moderate Interactions (Monitor Closely): - Erythromycin: moderate CYP3A4 inhibitor; may increase ebastine exposure. - Antihypertensive agents (e.g., beta‑blockers): additive sedative effect, monitor blood pressure. - Alcohol: can potentiate drowsiness and impair cognition.